awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
Graphs
1
Q26796405-01669581-6B9A-4468-B1C9-CC1EA693F00A
Q26796405-01669581-6B9A-4468-B1C9-CC1EA693F00A
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26796405-01669581-6B9A-4468-B1C9-CC1EA693F00A
Progress toward overcoming hypoxia-induced resistance to solid tumor therapy
P2860
Q26796405-01669581-6B9A-4468-B1C9-CC1EA693F00A
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26796405-01669581-6B9A-4468-B1C9-CC1EA693F00A
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
b7b97e824147eaccbfdddd2d48e109cb3afb6ad6
P2860
PR-104 a bioreductive pre-prodrug combined with gemcitabine or docetaxel in a phase Ib study of patients with advanced solid tumours